milnacipran has been researched along with omeprazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gibson, R; Ndikum-Moffor, F; Ogilvie, BW; Paris, BL; Parkinson, A; Scheinkoenig, JA | 1 |
1 review(s) available for milnacipran and omeprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for milnacipran and omeprazole
| Article | Year |
|---|---|
In vitro inhibition and induction of human liver cytochrome p450 enzymes by milnacipran.
Topics: Aged; Anti-Ulcer Agents; Antitubercular Agents; Cyclopropanes; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Hepatocytes; Humans; Hypoglycemic Agents; Male; Microsomes, Liver; Midazolam; Middle Aged; Milnacipran; Omeprazole; Selective Serotonin Reuptake Inhibitors; Testosterone | 2009 |